Two new studies that compared antipsychotics seek to fill that gap. The first, which Hamina led, measured the efficacy of ...

New five-year data reinforce long-term safety and efficacy of SPRAVATO® (esketamine) in patients with inadequate response to ...

Ahmedabad: Zydus Lifesciences Limited has announced that it has received in principle acceptability from World Health ...

Electric vehicle battery prices are likely to decline by nearly 50% by 2026, driven by technological advancements and falling metal costs. This… Taiwan Semiconductor Manufacturing Company (TSMC) is ...

Since they were not qualified to administer his now three-day overdue paliperidone injection, they provided him with a safety plan, advising him to take olanzapine overnight and to avoid alcohol ...

Former Brazil and Real Madrid defender Marcelo leaves Brazilian Serie A club Fluminense by mutual consent. Brazil's justice minister said the homicide was "evidently politically motivated". There ...

A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...

Some second-generation antipsychotics, including paliperidone and sertindole, showed slightly better cognitive outcomes but without significant benefits over placebo. Antipsychotics grouped by ...

Examples of the long-acting antipsychotics include paliperidone, sold under Invega Sustenna and other brand names, and risperidone, sold under Perseris and other brand names The cost impact of LAIs ...

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the United States Food and Drug Administration (USFDA) ...

Shares of Neuland Laboratories Ltd. saw its shares jump 15% to a record high, driven by a surge in export revenues, according to an analyst note. The company reported exports totaling $27 million for ...

Zydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are used to treat schizophrenia and schizoaffective disorders.